close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncolytics Biotech Inc. - Common Shares (NQ:ONCY)

1.261 +0.051 (+4.25%)
Streaming Delayed Price Updated: 1:11 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Oncolytics Biotech Inc. - Common Shares

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For August 8, 2025
 
Via Benzinga
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Earnings Preview: Oncolytics Biotech
 
Via Benzinga
Recap: Oncolytics Biotech Q4 Earnings
 
Via Benzinga
What to Expect from Oncolytics Biotech's Earnings
 
Via Benzinga
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
A Look at Oncolytics Biotech's Upcoming Earnings Report
 
Via Benzinga
What's going on in today's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
A Preview Of Oncolytics Biotech's Earnings
 
Via Benzinga
Oncolytics Biotech's Earnings Outlook
 
Via Benzinga
Oncolytics Biotech's Earnings: A Preview
 
Via Benzinga
5 Analysts Have This to Say About Oncolytics Biotech
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
Expert Ratings for Oncolytics Biotech
 
Via Benzinga
Earnings Scheduled For March 7, 2025
 
Via Benzinga
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer 
Via News Direct
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
3 Under-$20 Stocks to Buy for Explosive Returns
Are you looking to invest in stocks with massive potential? Here are three under $20 stocks to buy for explosive returns. 
Via InvestorPlace
Oncolytics Biotech: Q1 Earnings Insights
 
Via Benzinga
Oncolytics Biotech's Earnings: A Preview
 
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Earnings Scheduled For November 3, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
 
Via Benzinga
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
Via Benzinga
Earnings Scheduled For May 5, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today